Updated Jul 16, 2026 · Last SEC filing 2026-06-22
Editas Medicine, Inc. (EDIT) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-22. 6 Form 8-K material event filings were reported by EDIT in the last 90 days. 1 Form 144 notices of proposed sale were filed for EDIT stock. InsiderAlpha tracks every EDIT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001650664 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-06-22 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S — Open-market sale | 731 | $2.70 | $2K | SEC | |
| Parison Amy | SVP, Chief Financial Officer | S — Open-market sale | 464 | $2.70 | $1K | SEC | |
| O'Neill Gilmore Neil | CEO | S — Open-market sale | 15.4K | $2.70 | $42K | SEC | |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S — Open-market sale | 749 | $2.02 | $2K | SEC | |
| O'Neill Gilmore Neil | CEO | S — Open-market sale | 5.4K | $2.02 | $11K | SEC | |
| Parison Amy | SVP, Chief Financial Officer | S — Open-market sale | 474 | $2.02 | $957 | SEC | |
| O'Neill Gilmore Neil | CEO | S — Open-market sale | 5.6K | $2.15 | $12K | SEC | |
| Parison Amy | SVP, Chief Financial Officer | S — Open-market sale | 461 | $2.15 | $993 | SEC | |
| O'Neill Gilmore Neil | CEO | S — Open-market sale | 5.6K | $2.60 | $15K | SEC | |
| Parison Amy | SVP, Chief Financial Officer | S — Open-market sale | 458 | $2.60 | $1K | SEC | |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S — Open-market sale | 710 | $2.60 | $2K | SEC | |
| Parison Amy | SVP, Chief Financial Officer | S — Open-market sale | 679 | $2.58 | $2K | SEC | |
| Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S — Open-market sale | 5.1K | $2.49 | $13K | SEC | |
| O'Neill Gilmore Neil | CEO | S — Open-market sale | 1.6K | $2.08 | $3K | SEC | |
| Mei Baisong | EVP, CHIEF MEDICAL OFFICER | S — Open-market sale | 541 | $2.08 | $1K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Editas Medicine, Inc. (EDIT). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Connaughton Bernadette | 1 | — |
| Scadden David | 1 | — |
| Burkly Linda | 1 | $2K |
| Parison Amy | 1 | $1K |
| O'Neill Gilmore Neil | 1 | $42K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EDIT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live EDIT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.